To evaluate the significance of Cx43 gene expression levels in HER2+ breast cancer, we used the Kaplan-meier plotter database tool (kmplot.com) to assess whether Cx43 (GJA1) gene expression correlates with relapse free survival (RFS) in HER2+ patients [25]. This evidence concerns the gene ERBB2 and breast cancer.